Conversely, this property of JAK inhibitors can be harnessed in vaccine development to enhance viral yields in controlled settings, antiviral drug screening in IFN-sensitive cells and organoids as well as in oncolytic virus research to enhance virus-mediated death of tumours. The gene discussed is IFNA1; the disease is neoplasm.